Biodegradable pH/thermosensitive hydrogels for sustained delivery of biologically active agents
First Claim
1. A pharmaceutical composition for the sustained administration of an effective amount of a protein, comprising an injectable biodegradable polymeric matrix into which said protein has been incorporated, said polymeric matrix having reverse thermal gelation properties and pH-responsive gelation/de-gelation properties;
- wherein said polymeric matrix is a biodegradable block copolymer comprising;
(a) 55% to 80% by weight of a hydrophobic A polymer block comprising poly lactide-co-glycolide (PLGA) having an average molecular weight of between 1000-20,000; and
(b) 20% to 45% by weight of a hydrophilic B polymer block comprising a polyethylene glycol having an average molecular weight of between 500-10,000; and
wherein said biodegradable block copolymer has ionizable functional groups on one or both ends of the polymer chains.
1 Assignment
0 Petitions
Accused Products
Abstract
The present invention relates generally to the development of pharmaceutical compositions which provide for sustained release of biologically active polypeptides. More specifically, the invention relates to the use of pH/thermosensitive biodegradable hydrogels, consisting of a A-B di block or A-B-A tri block copolymer of poly(d,l- or l-lactic acid) (PLA) or poly(lactide-co-glycolide) (PLGA) (block A) and polyethylene glycol (PEG) (block B), with ionizable functional groups on one or both ends of the polymer chains, for the sustained delivery of biologically active agents.
-
Citations
7 Claims
-
1. A pharmaceutical composition for the sustained administration of an effective amount of a protein, comprising an injectable biodegradable polymeric matrix into which said protein has been incorporated, said polymeric matrix having reverse thermal gelation properties and pH-responsive gelation/de-gelation properties;
- wherein said polymeric matrix is a biodegradable block copolymer comprising;
(a) 55% to 80% by weight of a hydrophobic A polymer block comprising poly lactide-co-glycolide (PLGA) having an average molecular weight of between 1000-20,000; and
(b) 20% to 45% by weight of a hydrophilic B polymer block comprising a polyethylene glycol having an average molecular weight of between 500-10,000; and
wherein said biodegradable block copolymer has ionizable functional groups on one or both ends of the polymer chains.- View Dependent Claims (2, 3, 4, 5, 6, 7)
- wherein said polymeric matrix is a biodegradable block copolymer comprising;
Specification